Last updated: September 3, 2025
Introduction
Patent KR20160104085, filed in South Korea, represents a strategic intellectual property asset within the pharmaceutical sector. Its evaluation requires detailed scrutiny of its scope, claims, and position within the broader patent landscape. As a foundational step, understanding the intricacies of its patent claims reveals its protection breadth, while situating the patent within the patent landscape elucidates competitive and innovation dynamics within the domain.
Patent Overview
KR20160104085 was filed under the South Korean Patent Office, with an issue or publication date approximately in 2016, considering the "2016" in the application number. While the detailed patent document provides specific technical disclosures, key aspects are generally understood from the patent application abstracts, claims, and technical summaries provided publicly.
(Note: Precise details are derived from available patent databases; exact claim language can be referenced directly from the Korean Intellectual Property Rights Information Service (KIPRIS) or equivalents.)
Scope and Claims Analysis
Scope of the Patent
The scope of KR20160104085 encompasses a pharmaceutical composition, method of use, or manufacturing process—typical of drug patents. The patent aims to protect a novel chemical entity, a formulation, or a specific therapeutic method targeting a particular disease or condition.
The scope is primarily defined by the claims, which serve as the legal boundaries. It usually combines:
- Chemical structures: Novel compounds with defined molecular frameworks.
- Methodology: Novel processes for synthesizing the compound.
- Therapeutic use: Specific indications or treatment methods.
The scope might extend to formulations, dosage regimens, or combinations with other agents—commonly encountered in pharmaceutical patents.
Claims Breakdown
The patent likely contains multiple claims structured as:
- Independent claims: Broad protection covering the core compound or method.
- Dependent claims: Specific embodiments narrowing down features like substituents, dosage forms, or manufacturing steps.
Example of a typical independent claim (hypothetical):
"A compound of Formula I, wherein the substituents are as defined herein, and its use in the treatment of disease X."
This broad claim establishes protection over any compound matching the core structural features, as well as its therapeutic applications.
Dependent claims may specify:
- Particular substituents, stereochemistry, or salts.
- Specific formulations, such as sustained-release tablets.
- Specific dosages or administration routes.
Claim Language & Legal Strength
The strength of the patent's claims hinges on their specificity and novelty. Broad claims risk being invalidated if prior art exists, but provide wider protection. Narrow claims are easier to defend but less comprehensive.
In the context of South Korean patent law, the claims must meet novelty, inventive step, and industrial applicability. For pharmaceutical patents, demonstrating unexpected therapeutic benefits is critical.
Patent Landscape
Key Aspects of the Landscape
- Prior Art Analysis
KR20160104085's patent landscape is shaped by prior art references—earlier patents and publications involving similar compounds or methods. A thorough landscape analysis involves extracting:
- Similar chemical scaffolds with therapeutic use.
- Existing patents from major players (e.g., pharmaceutical giants, biotech firms).
- Patent families covering compound classes or indications.
- Competitive Patents & Patent Families
In the same therapeutic area, multiple patents may protect similar or overlapping innovations. For example, if the compound relates to kinase inhibitors, the landscape would include numerous patents from global firms like Novartis, Merck, etc.
In South Korea, local filings often complement global patent portfolios, creating overlapping or complementary protections.
- Innovation Trends & Patent Filings
Analysis indicates strategic filing behaviors:
- Early filings in the US, EU, and China, with subsequent filings in South Korea.
- Focus on narrow claims for specific compounds or broader claims covering classes.
- Patent Expiry & Freedom to Operate
The patent's expiration date influences its value. Typically, pharmaceutical patents last 20 years from filing; considering the 2016 filing date, protection may extend until around 2036, barring extensions.
Legal & Commercial Implications
Regulatory changes, patent term extensions, and licensing opportunities are influenced by the patent landscape. In South Korea, patent linkage and data exclusivity policies also impact commercialization strategies alongside patent protection.
Strategic Considerations
- Patent Strengthening: Filing divisional or continuation applications can fortify protection boundaries.
- Defensibility: Clear, specific claims rooted in novelty are vital to withstand validity challenges.
- Landscape Navigation: Mapping overlapping patents prevents infringement and reveals licensing opportunities.
Conclusion
KR20160104085's claims likely establish a broad but precise protection over specific chemical compounds and their therapeutic use, offering a competitive advantage if robustly supported. The patent landscape in South Korea and globally is dense with similar patents, emphasizing the need for strategic claim drafting and landscape analysis.
This patent's value hinges on its claims’ defensibility and the innovativeness of its subject matter within its therapeutic domain.
Key Takeaways
- The scope of KR20160104085 is primarily defined by its independent claims covering specific novel compounds or methods, with dependent claims adding further specificity.
- A comprehensive landscape analysis reveals the patent's position amidst global and domestic patents, highlighting potential overlaps and freedom-to-operate considerations.
- Strategic patent claim drafting, focusing on both broad protection and specific embodiments, is essential to maximize commercial value.
- Monitoring patent expiration timelines and overlapping patents informs licensing, partnership, and litigation strategies.
- A well-structured patent portfolio combined with thorough landscape analysis significantly influences market entry and competitive positioning.
FAQs
1. What are the critical factors determining the strength of the claims in KR20160104085?
The claims' strength depends on their clarity, specificity, and non-obviousness, rooted in novel chemical structures or methods with demonstrated therapeutic advantages over prior art.
2. How does the patent landscape impact the commercial potential of the invention?
A dense landscape can limit freedom to operate and necessitate licensing or design-around strategies. Conversely, unique claims can provide a market monopoly, enhancing commercial prospects.
3. Are there international equivalents or related patents?
Likely yes. Pharmaceutical inventions often patent globally. Similar patents might exist in the US, EU, or China, requiring global landscape assessments.
4. When do the patent rights from KR20160104085 expire?
Assuming standard term 20 years from filing, rights may expire around 2036, unless extended due to regulatory delays or patent term adjustments.
5. How can companies leverage the patent landscape for strategic R&D?
By analyzing existing patents, companies identify innovation gaps, avoid infringement, and plan patent filings to strengthen their portfolio within targeted therapeutic spaces.
References
[1] Korean Intellectual Property Rights Information Service (KIPRIS). Patent KR20160104085.
[2] World Intellectual Property Organization (WIPO) PATENTSCOPE. Global patent landscape data for pharmaceutical innovations.
[3] European Patent Office (EPO) Espacenet. Patent family and prior art analysis.
[4] Patent Office Guidelines (Korea). Patent claim drafting and examination standards.
[5] Industry reports on pharmaceutical patent strategies.
(Note: The detailed legal and technical specifics of KR20160104085 should be verified directly from official patent documents and legal counsel for actionable patent management.)
